IN2014MN00246A - - Google Patents
Info
- Publication number
- IN2014MN00246A IN2014MN00246A IN246MUN2014A IN2014MN00246A IN 2014MN00246 A IN2014MN00246 A IN 2014MN00246A IN 246MUN2014 A IN246MUN2014 A IN 246MUN2014A IN 2014MN00246 A IN2014MN00246 A IN 2014MN00246A
- Authority
- IN
- India
- Prior art keywords
- expression
- gene therapy
- invention concerns
- recombinant baculovirus
- therapy vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14041—Use of virus, viral particle or viral elements as a vector
- C12N2750/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/50—Vectors for producing vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2999/00—Further aspects of viruses or vectors not covered by groups C12N2710/00 - C12N2796/00 or C12N2800/00
- C12N2999/007—Technological advancements, e.g. new system for producing known virus, cre-lox system for production of transgenic animals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1156878A FR2978456B1 (fr) | 2011-07-27 | 2011-07-27 | Systeme baculoviral pour l'expression d'un vecteur de therapie genique |
| PCT/FR2012/051791 WO2013014400A1 (fr) | 2011-07-27 | 2012-07-27 | Systeme baculoviral pour l'expression d'un vecteur de therapie genique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00246A true IN2014MN00246A (ko) | 2015-09-25 |
Family
ID=46785752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN246MUN2014 IN2014MN00246A (ko) | 2011-07-27 | 2012-07-27 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10017783B2 (ko) |
| EP (1) | EP2737072B1 (ko) |
| KR (1) | KR20140049040A (ko) |
| CN (1) | CN103827306B (ko) |
| AU (1) | AU2012288681B2 (ko) |
| BR (1) | BR112014001859A2 (ko) |
| CA (1) | CA2843042C (ko) |
| DK (1) | DK2737072T3 (ko) |
| ES (1) | ES2666278T3 (ko) |
| FR (1) | FR2978456B1 (ko) |
| IN (1) | IN2014MN00246A (ko) |
| NO (1) | NO2737072T3 (ko) |
| PL (1) | PL2737072T3 (ko) |
| PT (1) | PT2737072T (ko) |
| SG (1) | SG2014006373A (ko) |
| WO (1) | WO2013014400A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3215602B1 (en) * | 2014-11-05 | 2019-12-25 | The Research Institute at Nationwide Children's Hospital | Methods and materials for producing recombinant viruses in eukaryotic microalgae |
| US11708585B2 (en) * | 2018-12-28 | 2023-07-25 | Wuhan Institute Of Physics And Mathematics, Chinese Academy Of Sciences | Method, system and recombinant bacmid for preparation of recombinant adeno-associated virus |
| CN109609552B (zh) * | 2018-12-28 | 2020-04-14 | 中国科学院武汉物理与数学研究所 | 重组腺相关病毒的制备方法、系统及重组杆粒 |
| KR102272651B1 (ko) * | 2019-03-28 | 2021-07-02 | 충북대학교 산학협력단 | 외래단백질의 발현량과 발현시간이 증대된 배큘로바이러스 |
| CA3190059A1 (en) * | 2020-08-17 | 2022-02-24 | Yu TAO | Nucleic acid construct for increasing adeno-associated virus yield, and construction method therefor |
| CN112852882A (zh) * | 2021-02-04 | 2021-05-28 | 中吉智药(南京)生物技术有限公司 | 一种杆状病毒感染昆虫细胞生产aav基因药物的系统及方法 |
| CN114369624B (zh) * | 2021-12-30 | 2023-07-14 | 华南农业大学 | 一种降低病毒感染导致的昆虫细胞凋亡的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7271002B2 (en) | 2001-11-09 | 2007-09-18 | United States Of America, Represented By The Secretary, Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| WO2004022760A1 (en) * | 2002-09-04 | 2004-03-18 | Polymun Scientific Immunbiologische Forschung Gmbh | Generation of recombinant influenza virus using baculovirus delivery vector |
| JP4597188B2 (ja) * | 2004-03-09 | 2010-12-15 | アイトゲネシシェ・テヒニーシェ・ホッホシューレ・チューリッヒ | 多タンパク質適用のための新規発現ツール |
| GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
| GB0820631D0 (en) | 2008-11-11 | 2008-12-17 | London School Hygiene & Tropical Medicine | Vectors |
| US8679837B2 (en) | 2009-04-02 | 2014-03-25 | University Of Florida Research Foundation, Inc. | Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors |
| EP2292781A1 (en) * | 2009-08-17 | 2011-03-09 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
-
2011
- 2011-07-27 FR FR1156878A patent/FR2978456B1/fr not_active Expired - Fee Related
-
2012
- 2012-07-27 CA CA2843042A patent/CA2843042C/fr not_active Expired - Fee Related
- 2012-07-27 US US14/234,988 patent/US10017783B2/en active Active
- 2012-07-27 IN IN246MUN2014 patent/IN2014MN00246A/en unknown
- 2012-07-27 EP EP12753763.7A patent/EP2737072B1/fr not_active Not-in-force
- 2012-07-27 PT PT127537637T patent/PT2737072T/pt unknown
- 2012-07-27 DK DK12753763.7T patent/DK2737072T3/en active
- 2012-07-27 PL PL12753763T patent/PL2737072T3/pl unknown
- 2012-07-27 ES ES12753763.7T patent/ES2666278T3/es active Active
- 2012-07-27 AU AU2012288681A patent/AU2012288681B2/en not_active Ceased
- 2012-07-27 KR KR1020147005352A patent/KR20140049040A/ko active IP Right Grant
- 2012-07-27 BR BR112014001859A patent/BR112014001859A2/pt active Search and Examination
- 2012-07-27 CN CN201280046259.9A patent/CN103827306B/zh not_active Expired - Fee Related
- 2012-07-27 SG SG2014006373A patent/SG2014006373A/en unknown
- 2012-07-27 WO PCT/FR2012/051791 patent/WO2013014400A1/fr active Application Filing
- 2012-07-27 NO NO12753763A patent/NO2737072T3/no unknown
-
2018
- 2018-07-09 US US16/029,870 patent/US10767192B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG2014006373A (en) | 2014-03-28 |
| AU2012288681A1 (en) | 2014-03-13 |
| AU2012288681B2 (en) | 2017-08-17 |
| WO2013014400A1 (fr) | 2013-01-31 |
| PL2737072T3 (pl) | 2018-08-31 |
| PT2737072T (pt) | 2018-05-08 |
| US20140349374A1 (en) | 2014-11-27 |
| EP2737072B1 (fr) | 2018-02-14 |
| FR2978456A1 (fr) | 2013-02-01 |
| US20180305717A1 (en) | 2018-10-25 |
| US10017783B2 (en) | 2018-07-10 |
| NO2737072T3 (ko) | 2018-07-14 |
| CA2843042A1 (fr) | 2013-01-31 |
| DK2737072T3 (en) | 2018-05-22 |
| US10767192B2 (en) | 2020-09-08 |
| KR20140049040A (ko) | 2014-04-24 |
| CN103827306A (zh) | 2014-05-28 |
| BR112014001859A2 (pt) | 2017-02-21 |
| CA2843042C (fr) | 2020-07-21 |
| ES2666278T3 (es) | 2018-05-03 |
| CN103827306B (zh) | 2018-10-09 |
| EP2737072A1 (fr) | 2014-06-04 |
| FR2978456B1 (fr) | 2015-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00246A (ko) | ||
| NZ630800A (en) | Methods of preparing substituted nucleotide analogs | |
| UY34780A (es) | Vectores virales para el tratamiento de distrofia retiniana | |
| IN2014CN00688A (ko) | ||
| HK1196849A1 (en) | Recombinant microorganism for the production of useful metabolites | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| GB201103062D0 (en) | Method | |
| IN2015DN00598A (ko) | ||
| MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
| MX365621B (es) | Nueva combinacion. | |
| IN2014DN06964A (ko) | ||
| IN2014DN07996A (ko) | ||
| HK1201560A1 (en) | Reduced genome bacteria with improved genetic stability | |
| SG191332A1 (en) | Recombinant mycobacterium as a vaccine | |
| EP2925753A4 (en) | Novel polymorphs of azilsartan medoxomil | |
| AP2014007650A0 (en) | Inhibition of viral gene expression | |
| EP2737050A4 (en) | RECOMBINANT APOA-1M FROM A BACTERIA PRODUCED BY GENETIC ENGINEERING | |
| MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
| HK1199064A1 (en) | Promoter derived from human gene | |
| IN2012DN01929A (ko) | ||
| IN2014DN10209A (ko) | ||
| MX2014002378A (es) | Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma. | |
| WO2014064714A3 (en) | Process for preparation of lurasidone hydrochloride | |
| PL2694033T3 (pl) | Leczenie zakażeń wirusowych | |
| EP2690171A4 (en) | ALSV RECOMBINANT FOR PREVENTING PATHOGEN VIRAL INFECTION OF A PLANT |